Fetal tissue engineering: In vitro analysis of muscle constructs

被引:23
作者
Fuchs, JR
Pomerantseva, I
Ochoa, ER
Vacanti, JP
Fauza, DO
机构
[1] Childrens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Harvard Ctr Minimally Invas Surg, Boston, MA USA
[3] Massachusetts Gen Hosp, Ctr Integrat Med & Innovat Technol, Boston, MA 02114 USA
关键词
tissue engineering; fetal; muscle; myoblast; fetal surgery; congenital anomalies; transplantation;
D O I
10.1016/S0022-3468(03)00394-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/Purpose: This study was aimed at examining the impact of different tissue engineering techniques on fetal muscle construct architecture. Methods: Myoblasts from ovine specimens of fetal skeletal muscle were expanded in culture and their growth rates determined. Cells were seeded at different densities onto 3 scaffold types, namely polyglycolic acid (PGA) treated with poly-L-lactic acid (PLLA), a composite of PGA with poly-4-hydroxylbutyrate (P4HB), and a collagen hydrogel. Constructs were maintained in a bioreactor and submitted to histologic, scanning electron microscopy, and DNA analyses at different time-points. Statistical analysis was by the likelihood ratio and paired Student's t tests (P < .05). Results: Fetal myoblasts proliferated at faster rates than expected from neonatal cells. Cell attachment was enhanced in the PGA/PLLA matrix and collagen hydrogel when compared with the PGA/P4HB composite. Necrosis was observed at the center of all constructs, directly proportional to cell seeding density and time in the bioreactor. Conclusions: Fetal myoblasts can be expanded rapidly in culture and attach well to PGA/PLLA, as well as collagen hydrogel but less optimally to PGA/P4HB. Excessive cell seeding density and bioreactor time may worsen final construct architecture. These findings should be considered during in vivo trials of muscle replacement by engineered fetal constructs. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1348 / 1353
页数:6
相关论文
共 24 条
[1]  
BIANCHI A, 1981, J PEDIATR SURG, V16, P42
[2]  
Chromiak JA, 1998, IN VITRO CELL DEV-AN, V34, P694
[3]   RECURRENT DIAPHRAGMATIC-HERNIA [J].
COHEN, D ;
REID, IS .
JOURNAL OF PEDIATRIC SURGERY, 1981, 16 (01) :42-44
[4]  
Cullen M L, 1996, Semin Pediatr Surg, V5, P243
[5]   OUTCOME FOR INFANTS WITH CONGENITAL DIAPHRAGMATIC-HERNIA REQUIRING EXTRACORPOREAL MEMBRANE-OXYGENATION - THE FIRST YEAR [J].
DAGOSTINO, JA ;
BERNBAUM, JC ;
GERDES, M ;
SCHWARTZ, IP ;
COBURN, CE ;
HIRSCHL, RB ;
BAUMGART, S ;
POLIN, RA .
JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (01) :10-15
[6]  
EYBL E, 1992, J THORAC CARDIOV SUR, V104, P763
[7]   Fetal tissue engineering: Diaphragmatic replacement [J].
Fauza, DO ;
Marler, JJ ;
Koka, R ;
Forse, RA ;
Mayer, JE ;
Vacanti, JP .
JOURNAL OF PEDIATRIC SURGERY, 2001, 36 (01) :146-151
[8]  
FAUZA DO, 2001, UNBORN PATIENT, P657
[9]  
Greenholz S K, 1996, Semin Pediatr Surg, V5, P216
[10]  
Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO